Mr. Speaker, I thank my friend, Mr. Andrews. Mr. Speaker, it will be a landmark day when we realize that health is not just about fixing broken bones. It's about having a healthy, complete individual…
Mr. Speaker, I thank my friend, Mr. Andrews.
Mr. Speaker, it will be a landmark day when we realize that health is not just about fixing broken bones. It's about having a healthy, complete individual from head to toe.
Today the House takes an important step to require mental health parity in insurance, and I particularly want to thank and recognize Patrick Kennedy and Jim Ramstad, and the late Paul and Sheila Wellstone.
Mr. Speaker, millions of Americans suffer from mental illness of some form. Few Americans are untouched and no one is immune.
Some of my colleagues have expressed their concern about the cost of providing mental health parity; yet an analysis of the bill indicates that it would result in an increase of less than 1 percent in premiums and would reduce out-of-pocket costs by about 18 percent. Further, according to a recent article in the Journal of the American Medical Association, employers who actively encourage their employees to use mental health services actually experience better health outcomes and, I want to emphasize this, increases in hours worked and productivity gained.
I include in the Record an editorial from the Journal of the American Medical Association from last September of 2007 dealing with the treatment of depression.
Reducing the Burden of Depression--Building Villages for Coordinated
Care
(Kenneth B. Wells and Jeanne Miranda)
In this issue of JAMA, Wang et al provide evidence that
implementing depression care programs through employer-
sponsored managed behavioral health can improve clinical
outcomes, job retention, and effective hours worked compared
with usual care. The programs encouraged depressed workers to
learn about and use evidence-based depression treatments,
supported clinicians in following practice guidelines, and
offered telephone counseling and self-help workbooks. The
monetary value of the increased work time under the program
exceeded the direct intervention costs and likely exceeded or
was within the range of cost increases due to greater mental
health specialty use under the intervention. While formal
estimates of cost-effectiveness and employer return on
investment are pending, it appears to be in the business
interests of many employers to implement such programs to
protect their investments in the retention and productivity
of workers they have hired and trained.
These findings should be evaluated within the context of
the simple but startling facts about depression. Clinical
depressive disorders are among the most prevalent of major
medical conditions, affecting about 16% of adults in their
lifetime. Owing to high prevalence, early age at onset
(unlike other debilitating disorders that occur past the age
of parenting and work responsibilities), and strong impact on
functional status, depressive disorders are leading
contributors to disability worldwide. Depressive disorders
are highly treatable yet often remain unrecognized and
untreated. While a number of effective programs promote
higher use of treatments in service delivery settings,
particularly primary care practices, these programs are not
yet widely implemented. Thus, technology is available to
treat this disabling condition, but US health care systems
have failed to take full advantage of the technology to
reduce personal or societal consequences of depression.
The intervention approach in the study by Wang et al can be
characterized as ``building a village'' of health plans,
clinicians, and resources that ``surround'' depressed persons
with opportunities to learn about and engage in evidence-
based care, attending to a careful fit of intervention
requirements and context-specific implementation options.
This approach has generally proven effective in primary care,
and the substantial outreach efforts mirror those in the WE
Care study demonstrating that depression treatments are
effective for low-income and minority women. In the study by
Wang et al telephone managers from the behavioral health
company offered counseling and communicated recommendations
to clinicians, an extension of their usual role. In the
Partners in Care study, primary care nurses expanded their
disease management skills to include assessment, education,
and follow-up concerning depression. In both studies,
patients and clinicians were free to use or not use study
resources according to their preferences. Such interventions
have the advantage of preserving the naturalistic context of
the delivery systems, potentially facilitating the
translation of findings into change by example. Interventions
in both studies achieved roughly similar outcomes: a 10
percentage-point gain in use of appropriate treatment and in
recovery from depression over a year, as well as roughly 2
more weeks of days worked in a year in the study by Wang et
al and a month more of days worked over 2 years in Partners
in Care.
Depression interventions have many advantages for
individuals, their family and friends, employers and society,
over and above relief of individual symptoms. As mothers'
depression improves following care, for example, their
children also enjoy improvements in mental health. The study
by Wang et al demonstrates that treatment of depression
increases productivity and may reduce economic losses due to
depression for employees and employers. If such gains exceed
costs of providing the interventions and treatments, there is
``money on the table'' across stakeholders that could be used
to pay for interventions. Why then do many individuals with
depression endure their illness without care?
One barrier to care is that depression affects motivation
and cognition, making it difficult for many individuals with
depression to realize they have a need and obtain care
without the outreach provided by nurse/care managers. Family
members also may fail to identify depression or have
knowledge about appropriate care. This suggests that
opportunities to improve access to depression care should be
embedded within an infrastructure available to potentially
depressed persons, such as primary care settings. However, an
awareness of the effects of treatment on social costs such as
productivity may not provide a strong incentive for
clinicians and health plans to improve care, as they do not
necessarily face immediate financial consequences from
patients' changes in productivity or may not track this
outcome. Yet most private health care in the United States is
financed through employer-sponsored insurance. Direct
contributions to the bottom line of employers offers them an
incentive to promote depression care, independent of policy
mandates or other motives such as responding to employee
demand.
Other stakeholders, including policy makers and the public,
may benefit from improved depression care through an
increased tax base from employees who work more or an overall
improved economy. Yet it is challenging in the US policy
environment to use economic gains from one policy sector such
as the labor market as leverage to support improved health
care, However some policy changes could be implemented to
better align the incentives to implement depression care
programs across diverse stakeholders and to avoid undermining
the goals of such programs, for example by excluding
depression treatment from health insurance coverage when
changing jobs or insurance based on a recent history of
depression treatment in an employer-based depression program.
Under such an ill-advised policy, the risk of losing coverage
would serve as a major deterrent to seeking care.
The need to coordinate program implementation and policy
suggests an expanded concept of ``a village,'' that includes
not only wrap-around interventions but coordinated efforts
across affected stakeholders. It may be trite that the
stakeholder with the most power to influence services
delivery for most Americans is the employer, but broader and
deeper change in access to depression care may yet require a
concerted effort among affected parties to yield prograns
that address public and self-stigma and to provide access to
depression treatments under policies that
facilitate use of such programs and do not penalize
individuals for using them. Studies such as that by Wang et
al strongly support such integrated solutions.
Exactly how programs to improve depression care are
implemented may affect the distribution of benefits--an
important issue given evidence of disparities in quality of
depression care and the potential for practice-based programs
to overcome disparities in depression outcomes. Developers of
interventions and policies should consider implications of
their design for inclusion of underserved groups who may not
seek behavioral health care. Despite the extensive efforts by
Wang et al to reach general employees, the majority of
persons had already inquired about outpatient care. Learning
how to optimize personal and societal gains by improving
access to quality depression care across diverse communities
through employer, practice, and community-based programs and
policy changes is a next agenda for evidence-based action. As
a community participant in the Witness for Wellness program
recently stated: ``Depression is everybody's business.''
Now, ultimately, despite the economic arguments in favor of parity, it is not a debate about dollars and cents but about lives saved and people restored. Let's work to ensure that those who need access to mental health will get it.
Mr. Speaker, it will be a landmark day when we realize that health is not just about fixing broken bones. It's about having a healthy, complete individual from head to toe. Millions of Americans suffer from mental illness of some form, conditions that disrupt a person's thinking, feeling, mood, ability to relate to others, and daily functioning. Mental illnesses strain families and can contribute to lost productivity, unemployment, substance abuse, homelessness, or suicide. Few Americans are untouched by it. No one is immune.
Prompt and comprehensive treatment can reduce enormously these effects, but insurance companies--including government plans like Medicare, Medicaid, and the State Children's Health Insurance Program (SCHIP)--frequently impose limits on coverage for mental health that are not imposed on traditional medical and surgical care. Already this year, Congress has worked to address these inequalities in the federal health programs.
Today, the House of Representatives is taking a significant step toward finally ending the insurance discrimination that has existed for decades against people with mental illness.
Representative Patrick Kennedy and Representative Jim Ramstad deserve credit for their strong leadership on the Paul Wellstone Mental Health and Addiction Equity Act, H.R. 1424, which I am proud to cosponsor along with more than 270 of my colleagues. This much needed legislation would require insurance companies to provide benefits for mental health and substance abuse treatment equal to those provided for physical medical treatment.
The Paul Wellstone Mental Health and Addiction Equity Act would require that all Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, illnesses be covered, rather than letting insurance companies determine their own scope of coverage. This is the same coverage requirements that we as Members of Congress receive under our federal employee health plan, and our constituents deserve no less coverage.
The American Psychological Association, which publishes DSM-IV, reports that lack of insurance coverage (87 percent) and cost (81 percent) are the leading factors for individuals not seeking mental health services. The Paul Wellstone Mental Health and Addiction Equity Act would solve both of these problems.
Additionally, unlike the bill working through the Senate, H.R. 1424 would not preempt state law. This is very important for the residents of my home state of New Jersey and others who already have mental health parity laws on the books. For good reason these states worry that they might be forced to reduce their coverage requirements.
We know that mental illness is treatable, yet because one third of the people affected do not receive needed treatments, mental illness remains a leading cause of disability and premature death. According to the World Health Organization, the costs related to untreated mental illness are $147 billion each year in the United States. Those who oppose the legislation thinking it is too expensive should note this cost.
Yet, an analysis of the Paul Wellstone Mental Health and Addiction Equity Act indicates it would result in an increase of less than one percent premiums and would reduce out-of-pocket costs by 18 percent. Further, a recent article in the Journal of American Medical Association, JAMA, indicates that employers who actively encourage their employees to use mental health services actually experienced an increase in hours worked and productivity gains.
Ultimately, despite the economic arguments in favor of parity, it is not a debate about dollars and cents, but about lives saved and people restored. I recently received a letter from a constituent who is a corporate human resource director. She did not write me in that capacity, however. Instead, she wrote me ``as the sister of a beloved brother who committed suicide one day after his in-patient mental health care benefit `ran-out'.'' She understood and related to me not only the human resources concerns, but also and especially, the true cost of mental health and the failure to enact mental health parity. Let's work to ensure that those who need access to mental health care, get it.